<110> AKSEERA PHARMA CORP., Patel, Manit and Merchant, Shreema

<120> Interaction of SARS-CoV-2 proteins with molecular and cellular mechanisms
of host cells and formulations to treat COVID-19

<140> PCT/IN2021/050325

<141> 30/03/2021

<160> 14

<210> 1
<211> length 20 bp
<212> IFN-gamma
<213> Homo sapiens
<400> 1
Forward 5'-TGGCTTTTCAGCTCTGCATC-3'


<210> 2
<211> length 21 bp
<212> IFN-gamma
<213> Homo sapiens
<400> 2
Reverse 5'-CCGCTACATCTGAATGACCTG-3'

<210> 3
<211> length 20 bp
<212> IFN-lambda 1
<213> Homo sapiens
<400> 3
Forward 5' - GAGGCCCCCAAAAAGGAGTC - 3'


<210> 4
<211> length 20 bp
<212> IFN-lambda 1
<213> Homo sapiens
<400> 4
Reverse 5' - AGGTTCCCATCGGCCACATA - 3'


<210> 5
<211> length 20 bp
<212> IFN-lambda 2/3
<213> organism Homo sapiens
<400> 5
forward 5′-CTGCCACATAGCCCAGTTCA-3'

<210> 6
<211> length 25 bp
<212> IFN-lambda 2/3
<213> Homo sapiens
<400> 6
reverse 5′-AGAAGCGACTCTTCTAAGGCATCTT-3'


<210> 7
<211> length 22 bp
<212> MX1
<213> Homo sapiens
<400> 7
Forward 5’-GGCTGTTTACCAGACTCCGACA-3’

<210> 8
<211> length 22 bp
<212> MX1
<213> organism Homo sapiens
<400> 8
Reverse 5’-CACAAAGCCTGGCAGCTCTCTA-3’

<210> 9
<211> length 19 bp
<212> OAS1
<213> Homo sapiens
<400> 9
Forward 5'- GAA GGC AGC TCA CGA AAC C -3’ 


<210> 10
<211> length 18 bp
<212> OAS1
<213> Homo sapiens
<400> 10
Reverse 5'- AGG CCT CAG CCT CTT GTG -3’



<210> 11
<211> length 21 bp
<212> IFIT1 
<213> Homo sapiens
<400> 11
Forward 5’-GGAATACACAACCTACTAGCC-3’


<210> 12
<211> length 20 bp
<212> IFIT1 
<213> Homo sapiens
<400> 12
Reverse 5’-CCAGGTCACCAGACTCCTCA-3'


<210> 13
<211> length 20 bp
<212> hGapdh
<213> Homo sapiens
<400> 13
forward 5’-AGAAGGCTGGGGCTCATTTG-3’


<210> 14
<211> length 20 bp
<212> hGapdh
<213> Homo sapiens
<400> 14
reverse 5’-AGGGGCCATCCACAGTCTTC-3’